Articles tagged childhood vaccines

‘Reckless in the extreme’: FDA panel recommends new RSV shot for use in healthy infants

Advisers to the U.S. Food and Drug Administration on Thursday recommended approval of AstraZeneca’s new monoclonal antibody, which the drugmaker said is designed to protect infants and toddlers up to age 2 from respiratory syncytial virus, but medical experts interviewed by The Defender called the move 'reckless' and 'preposterous.'
News
Michael Nevradakis Ph. D., The Defender
 • 

‘Independent’ advisor who evaluated Pfizer vaccine safety was former paid Pfizer consultant

Dr. Kathryn Edwards, a well-known vaccinologist who served on the data monitoring committee charged with ensuring the safety and efficacy of the Pfizer-BioNTech COVID-19 vaccine, previously worked as a paid consultant and advisor to Pfizer. A closer look into Edwards’ credentials reveals this was just one of many conflicts of interest.
News
Michael Nevradakis Ph. D., The Defender
 •